Welcome to the Co-occurring Substance Misuse and Mental Health Issues Profiling Tool. It has been developed to support an intelligence-driven approach to understanding and meeting need. It collates and analyses a wide range of publically available data around tobacco smoking, alcohol use and drug use, including data on prevalence, risk factors, treatment demand and treatment response. The tool also features indicators around mental health prevalence and services. From December 2016, it will also feature related indicators on mortality.
The tool provides commissioners, service providers, clinicians, service users and their families with the means to benchmark their area against other areas.
Although much of the data is already available, either in the public domain or through supporting data sent to local authority commissioners, this profiling tool pulls together relevant data from different sources into one place for the first time.
At the present time we lack good, direct local indicators of the levels of co-morbid substance misuse and mental health issues. However, the available research literature demonstrates strong links between mental health and smoking, alcohol use and drug use. Smoking is much more common among those with mental health disorders (McManus et al, 2010), and most users of drug and alcohol services also experience mental health problems (Weaver et al, 2003). Based on these associations, we have chosen, in lieu of more specific data, to release overall data around smoking, alcohol use and drug use, as well as data around mental health prevalence and services.
Tool structure - data is presented under the headings Prevalence and Risks, Treatment Demand and Treatment Response. Within these it is grouped by local authority area.
Tool content - data is drawn from various sources and varies by time period, population and presentation of values. Care should be taken with interpretation. Detailed metadata and any caveats are set out in the Definitions section.
Data quality - indicators are included if viewed as robust, of sufficient quality, or they offer an important element that could not be otherwise gained. Each indicator has been assessed and labelled with its quality rank.
1. McManus, S., Meltzer, H., & Campion, J. (2010). Cigarette smoking and mental health in England. Data from the Adult Psychiatric Morbidity Survey. National Centre for Social Research.
2. Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., ... & Ford, C. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry, 183(4), 304-313.
Six indicators on substance misuse treatment have been updated with 2015/16 data.
- A new section has been added to the tool showing related mortality indicators, including deaths attributed to drug, alcohol and tobacco use, suicide rates and premature mortality among people with serious mental illness.
- Indicators have been added to the tool on i) smoking prevalence among people with serious mental illness, ii) proportion of adults with substance misuse issues engaging with community treatment upon release from prison
- Other indicators have been updated where newer data is available.
- A new section has been added to the tool showing indicators around mental health prevalence and service provision in each local area.
- A 'risk and related factors' section has been added, including indicators around deprivation, unemployment, homelessness and crime at local population level.
- Indicators on substance misuse treatment have been backdated to 2013/14 to take into account the methodological changes described in January's update.
- Indicators on substance misuse treatment services drawn from NDTMS have been updated to 2014/15 and have been subject to methodological changes. There will be a further update in February which will backdate these changes.
- Other indicators (smoking prevalence, alcohol hospital admissions for mental health and stop smoking service data) have been updated with newer data. Prevalence of opiate and/or crack cocaine use has not been updated as no newer estimates are available.
First version released